Bioanalytical Sciences was acquired by LGC on 24 December 2012. Please see the following press release for further details: LGC acquires leading bioanalytical sciences business from Quotient Bioresearch
Our Bioanalytical Sciences laboratory is purpose built and equipped with the latest state-of-the-art instrumentation and technologies. Our scientists are highly skilled and receive the very best training and development to provide you with robust data you can rely on and the service you expect.
Small molecule and peptide bioanalysis technology platforms include:
Biopharmaceutical analytical methods and technology platforms include:
Central laboratory analytical methods and technology platforms include:
Immunology and clinical chemistry
LC - Liquid Chromatography; MS - Mass spectometry; GC-MS/MS - Gas chromatography mass spectometry; UPLC - Ultra performance liquid chromatography; ELISA -Enzyme-linked immunosorbent assay; EIA - Enzyme Immuno Assay; IRMA - Immunoradiometric assay; RIA - Radioimmunoassay; BioMS™ - Biologicals measured by mass spectrometry; MSD® - Meso Scale Discovery; STAT -abbreviation of the Latin word statim meaning "immediately" or urgent often used in medical contexts